Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
As of the end of May 2023, Medicilon has successfully assisted in the clinical approval of 7 GLP-1 drugs (3 approved by FDA and NMPA1 approved by FDA, NMPA, and TGA) and has multiple GLP-1 projects under development
Retatrutide is being developed by Eli Lilly and Company , the same pharmaceutical company behind Mounjaro (tirzepatide) and the oral GLP-1 weight loss medicine Foundayo (orforglipron)
What it Does: Gently begins the detoxification process in the liver, clearing free radicals and preparing the skin for a brighter, more even tone
US$ 24.91
US$ 22.43
US$ 24.40
